Covidien Looking to Acquire Companies With Annual Sales of $20-120M

Covidien CEO, Jose Almeida, said the company is looking to acquire companies with annual sales of $20-120 million in its vascular, respiratory and surgical businesses, according to a Bloomberg News report.

According to Bloomberg, Covidien announced or completed 20 deals in the past five years with an average size of $304 million.

Related Articles on Medical Devices:

Three-Quarters of California Biomedical Companies Delayed Research or Development Last Year
BG Medicine Names Eric Bouvier President and CEO
10 Recent FDA Medical Device Approvals

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers